HTG2014-Section-Header-publications

Categories

Filter by Topics

ALK Apoptosis Asthma Autocrine Signaling B Cells benign Biofluid Biomarker Analysis Biomarker Discovery Biomarker Validation Biomarkers Bladder Cancer Breast Cancer Breast milk Cancer Genomics Cells Cerebrospinal Fluid Childhood Atopic Dermatitis Chronic Obstructive Pulmonary Disease Circulating miRNAs Colorectal cancer Comparative Study Comparison study computational toxicology Core Needle Biopsy COVID-19 Custom mRNA Cytokines Cytotoxic T Cells Dementia Diabetes Differential Expression Differential Gene Expression Analysis DLBCL Drug Response Drug Safety Drug Targets Drug-induced Liver Injury EGFR Muatations EMT epidemiology epigenomics Epstein-Barr Esophageal Cancer Exosomes Extracellular Vesicles Fabry Disease Feasibility FFPE FGF Ligand Trap Fibrous Tumors Gene Expression Profiling Gene Signature Analysis Glioblastoma Tumors Head and Neck Cancer Heart HTG EdgeSeq ALKPlus Assay EU HTG EdgeSeq Custom Assays HTG EdgeSeq DLBCL Cell of Origin Assay HTG EdgeSeq DLBCL-COO-CE-IVD HTG EdgeSeq Immune Response Panel HTG EdgeSeq Immuno-Oncology Assay HTG EdgeSeq miRNA Whole Transcriptome Assay HTG EdgeSeq miRNA Whole Transcriptome Panel HTG EdgeSeq Mouse mRNA Tumor Response Panel HTG EdgeSeq Oncology Biomarker Panel HTG EdgeSeq Path Assay HTG EdgeSeq Precision Immuno-Oncology Panel HTG EdgeSeq Precision Immunol-Oncology Panel HTG EdgeSeq System HTG EdgeSeq System Oncology Biomarker Panel HTG EdgSeq Immuno-Oncology Assay ibrutinib Immune Checkpoint Inhibitors Immune Related Genes Immune Response Immune Tolerance Immuno-Oncology immunohistochemistry IHC Immunotherapy Inflammation Juvenile Arthritis Kidney Liquid Biopsy Liver Lung Lung cancer Lymph Node Metastasis Lymphoma machine learning malignant Mechanism of Action Melanoma Mesothelioma Microenvironment MicroRNA miRNA Molecular Characterization Mouse mRNA custom mTOR pathway multi-omics Muscle Mutations NAFLD Nash and Fibrosis Neoantigens Neuroendocrine Tumor Neurologic Oncology Oral Cancer Osteoclast Ovarian cancer Pancreas Paralysis Pathogenesis Pathway analysis Pathway Analysis PCA Cell Lines PD-1 PD-L1 Placenta placenta Plasma predictive biology Predictive Biomarkers Predictive Modeling Progression free-survival Prostate Prostate Cancer qNPA Reproductive Response rate Reveal Rheumatoid Arthritis Risk Score Sarcoma Serum Signaling Inhibitors Signatures Sinonasal Carcinoma Skin SPECS Lung Consortium Squamous cell carcinoma Sub-typing surface plasmon Surveillance Survival Outcomes Synovial Fluid synthetic miRNA T-Cell T-cells Technology Comparison Therapeutic targets Thyroid Cancer TMB Toxicity Translational Medicine Treatment Outcome Tumor Biology Tumor Heterogeneity Tumor Microenvironment Urothelial carcinoma Uterus Wound healing Xenograft Tissue

2021

Pre-pregnancy BMI-associated miRNA and mRNA expression signatures in the placenta highlight a sexually-dimorphic response to maternal underweight status

Clark, J., et al. Pre-pregnancy BMI-associated miRNA and mRNA expression signatures in the placenta highlight a sexually-dimorphic response to maternal underweight status. Scientific Reports (2021) DOI: 10.21203/rs.3.rs-478026/v1

Download pdf 761KB

Gene expression comparison between primary estrogen receptor-positive and triple-negative breast cancer with paired axillary lymph node metastasis

Srour, M., et al. Gene expression comparison between primary estrogen receptor-positive and triple-negative breast cancer with paired axillary lymph node metastasis. Breast J. 2021 JAN 19. Jan 19. doi: 10.1111/tbj.14119. Online ahead of print

Download pdf 909KB

2020

Comparative analysis of gene expression platforms for cell-of-origin classification of diffuse large B-cell lymphoma shows high concordance

Ahmed, S., et al. Comparative analysis of gene expression platforms for cell-of-origin classification of diffuse large B-cell lymphoma shows high concordance. Br J Haematol. 2020 Nov 29. doic 10.1111/bjh.17246. Online ahead of print

Download pdf 943KB
View External Link

A phase 2 study of tislelizumab in combination with platinum-based chemotherapy as first-line treatment for advanced lung cancer in Chinese patients

Wang, Z., et al. A phase 2 study of tislelizumab in combination with platinum-based chemotherapy as first-line treatment for advanced lung cancer in Chinese patients. Lung Cancer 147(2020) 259-268. 

Download pdf 4.3MB

Gene expression analysis in formalin fixed paraffin embedded melanomas is associated with density of corresponding immune cells in those tissues.

Kwak, M., et al. Gene expression analysis in formalin fixed paraffin embedded melanomas is associated with density of corresponding immune cells in those tissues.Gene expression analysis in formalin fixed paraffin embedded melanomas is associated with density of corresponding immune cells in those tissues. Scientific Reports (2020) 10:18336. https://doi.org/10.1038/s41598-020-74996-9 Nature Research

Download pdf 1.3MB

Page last updated September 16, 2021